Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe - a Hungarian nationwide observational study

[1]  P. Rutgeerts,et al.  751f One Year Data from the Sonic Study: A Randomized, Double-Blind Trial Comparing Infliximab and Infliximab Plus Azathioprine to Azathioprine in Patients with Crohn's Disease Naive to Immunomodulators and Biologic Therapy , 2009 .

[2]  F. Nagy,et al.  Is the efficacy of successful infliximab induction therapy maintained for one year lasting without retreatment in different behavior types of Crohn's disease? , 2008, Journal of Crohn's & colitis.

[3]  K. Van Steen,et al.  Long-term outcome of treatment with infliximab in 614 patients with Crohn’s disease: results from a single-centre cohort , 2008, Gut.

[4]  A. Cohen,et al.  A Randomized Trial of Methotrexate in Combination With Infliximab for the Treatment of Crohn's Disease , 2008 .

[5]  P. Rutgeerts,et al.  T1048 No New Safety Signals Identified in Crohn's Disease Patients Treated with Infliximab in An Interim Review of the ENCORE Registry , 2008 .

[6]  P. Rutgeerts,et al.  LONG-TERM OUTCOME OF TREATMENT WITH INFLIXIMAB IN 440 CROHN'S DISEASE PATIENTS: RESULTS FROM A SINGLE CENTER COHORT , 2007 .

[7]  Z. Tulassay,et al.  Repeated infliximab therapy after serum sickness-like reaction in Crohn's disease. , 2007, Journal of Emergency Medicine.

[8]  B. Wallaert,et al.  Successful induction of tolerance to infliximab in patients with Crohn's disease and prior severe infusion reactions , 2006, Alimentary pharmacology & therapeutics.

[9]  W. Sandborn,et al.  Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[10]  Paul Rutgeerts,et al.  Infliximab for induction and maintenance therapy for ulcerative colitis. , 2005, The New England journal of medicine.

[11]  F. Rizzello,et al.  Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open study. , 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[12]  V. Annese,et al.  Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement. , 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[13]  M. Bala,et al.  Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. , 2005, Gastroenterology.

[14]  L. Insabato,et al.  Successful treatment of therapy‐resistant metastatic Crohn's disease with infliximab , 2004, The British journal of dermatology.

[15]  R. Ricketts.  Infliximab in the treatment of Crohn’s disease: a user’s guide for clinicians: W. Sandborn and S. Hanauer. Am J Gastroenterol 97:2962–2972 (December), 2002 , 2004 .

[16]  M. Peppercorn,et al.  Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: a randomized controlled trial. , 2003, Gastroenterology.

[17]  S. Hanauer,et al.  Infliximab in the treatment of Crohn's disease: a user's guide for clinicians , 2002, American Journal of Gastroenterology.

[18]  J. Belaiche,et al.  Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's disease , 2002, American Journal of Gastroenterology.

[19]  D. Hommes,et al.  Infliximab Treatment for Crohn's Disease: One-Year Experience in a Dutch Academic Hospital , 2002, Inflammatory bowel diseases.

[20]  R. Cohen.  Efficacy and safety of repeated infliximab infusions for Crohn's disease: 1-year clinical experience. , 2001, Inflammatory bowel diseases.

[21]  Samir A. Shah,et al.  Clinical experience with infliximab therapy in 100 patients with Crohn's disease , 2000, American Journal of Gastroenterology.

[22]  I. Forgacs.  GASTROENTEROLOGY , 1988, The Lancet.